Richmar® is presenting its new MicroBlock, an electrode system designed to inhibit and kill growth of common disease-causing bacteria in TENS (transcutaneous electrical nerve stimulation) therapy devices.
The device was demonstrated at the American Physical Therapy Association Combined Sections Meeting last week.
MicroBlock was designed to prevent infection and the risk of contamination in electrotherapy devices in healthcare settings, executives said.
“Scientific testing of MicroBlock, in research and development for 16 months, has proven its efficacy in dispatching infection-causing bacteria,” Richmar Senior VP Ryan Moore said. “Not only do no other electrodes protect your patients against infection, but MicroBlock has been tested to maintain antimicrobial performance over the ten-application lifespan of the electrode.”
MicroBlock is effective at killing E. cloacae (CRE), S. aureus, E. coli, E. faecalis, P. aeruginosa and A. baumannii.